Microwave ablation (MWA)

Microwave ablation (MWA) is a minimally invasive medical procedure used to treat certain types of tumors. During MWA, a specialized electrode is inserted into the tumor, guided by imaging techniques such as ultrasound or CT scans. MWA offers several benefits, including reduced recovery time, less pain, and a lower risk of complications compared to traditional surgery. 

Mechanism of Action:

Thermal Ablation (Hyperthermic) –  Microwave heating is produced as a result of dielectric hysteresis (rotating dipoles).

  • Cellular Homeostatic Mechanism – upto 40ºC
  • Cytotoxic temperature is needed (> 50 ºC, between 50-100)
  • Increased susceptibility to chemical and radiation injury – 42-45 ºC
  • Irreversible cellular damage – 46 ºC for 60 mins, 50 ºC for 5 min ( temp > 50 – surrogate marker)
  • Tissue vaporisation and gas formation – 105 ºC

Coagulation of cytosolic and mitochondrial enzyme with formation of nucleic acid – histone protein complex leads to coagulation necrosis  (used to describe this thermal damage even though the manifestations of cell death following high-temperature thermal ablation may not fulfill strict histopathologic criteria of coagulative necrosis).

Tissue Characterstics:

Tissue CharacteristicsFeatures
Tissue Perfusion1. Heat-Sink Effect / Perfusion mediated cooling
2. Foremost factor limiting thermal ablation = Blood flow carries thermal energy away from the targeted tissue​.
3. Most veins greater than 3 mm remain patent after RF ablation resulting in less endothelial injury and irregular ablation zones
4. Effect reduced after arterial embolization methods like coils, particles, balloons, or lipiodol agents
Thermal Conductivity1. Oven Effect
2. Poor Thermal Conductivity or Increased heating efficacy for tumors surrounded by cirrhotic liver/ fat.​
3. Increased Thermal Conductivity eg. cystic lesion = fast heat transmission and dissipation = more time required to reach cytotoxic temperature = potentially incomplete or heterogeneous tumor heating
Electrical Conductivity
(Radiofrequency ablation)
1. Ionic agent like normal saline increase conductivity​ = NS injection in and around ablation site​ results in better local heating effect
2. Non-Ionic agent hamper the electrical conductivity​ = Dextrose 5% used for hydrodissection and protection of adjacent organ
3. Tumor-organ interface with marked difference in electric conductivity (like lung, bone) = limited heating of adjacent organ = difficult to obtain 1 cm ablative margin
Dielectric Properties
(Microwave Ablation)
1. Relative Permittivity - charge storing capacity of material
2. Bulk Conductivity - Energy loss inside material
3. Dielectric properties of tissue correlate well with their water contents, therefore tissue conductivity increases with increasing water content.

Generation of MWA equipment:

  • First-Generation systems – lack active antenna cooling, limited to low power and short durations.
  • Second-Generation systems have antenna cooling but limited generator power.
  • Third-Generation systems incorporate antenna cooling and high-power generators.

Technical Advantage of MWA over RFA:

  • Faster Ablation
  • Higher temperature without the limitations related to electrical impedance
  • Less sensitivity towards tissue type
  • More consistent results
  • Beneficial in treating some tumors resistant to treatment with RFA (sarcoma and hemangiopericytoma)
  • Relative insensitivity to heat sink

Contraindications:

Absolute contraindications include

  1. Patient refusal
  2. Increased intracranial pressure, and
  3. Local infection.

Relative contraindications include

  1. Deranged coagulation or patient on anticoagulation

Complications:

  1. Bleeding – Entry site,  Access route, target area
  2. Infection
  3. Tumor Seeding – Tract ablation is recommended.
  4. Needle placement-induced nerve damage
  5. Post-Ablation Syndrome (transient) – Flu-like symptoms and generally low-grade fever.

1. Glassberg MB, Ghosh S, Clymer JW, Qadeer RA, Ferko NC, Sadeghirad B, Wright GW, Amaral JF. Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. Onco Targets Ther. 2019 Aug 13;12:6407-6438. doi: 10.2147/OTT.S204340. PMID: 31496742; PMCID: PMC6698169.

2. Lu DS , Raman SS , Limanond P , et al. Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol 2003 ; 14 ( 10 ): 1267 – 1274
3. Hakimé A , Hines-Peralta A , Peddi H , et al. Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice. Radiology 2007;244 ( 2 ): 464 – 470.
4. Ahmed M , Liu Z , Humphries S , Goldberg SN. Computer modeling of the combined effects of perfusion, electrical conductivity, and thermal conductivity on tissue heating patterns in radiofrequency tumor ablation. Int J Hyperthermia 2008 ; 24 ( 7 ): 577 – 588.
5. Schepps JL , Foster KR . The UHF and microwave dielectric properties of normal and tumour tissues: variation in dielectric properties with tissue water content . Phys Med Biol 1980 ; 25 ( 6 ): 1149 – 1159

6. Wray JK, Dixon B, Przkora R. Radiofrequency Ablation. [Updated 2023 Apr 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK48238

7. Ahmed M, Brace CL, Lee Jr FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology. 2011 Feb;258(2):351-69.

Skip to content